TGBMF yields 3.50% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, TGBMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TGBMF + JNJ for your $10,000?
Taiwan Cement Corporation manufactures and markets cement, cement-related products, and ready mix concrete in Taiwan. It operates through Cement, Chemical Engineering, Electricity, and Other segments. The company also exports cement and cement clinkers. In addition, the company generates thermal and renewable energy; processes and sells refractory, chemical, and rubber raw materials, and batteries; sells limestone; and offers property leasing and energy technology, information software design, afforestation, industrial port management, marine transportation, engineering, construction and lease, waste collection and treatment, business consulting, port facility, software product and equipment maintenance, logistics and transportation, and dangerous waste treatment services. Further, it is involved in the sand and gravel filtering and sale; import and export trading; warehousing, and transportation; mining excavation activities; and manufacture and sale of slag powder. Taiwan Cement Corporation was incorporated in 1946 and is headquartered in Taipei, Taiwan.
Full TGBMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.